Published in J Am Soc Nephrol on April 14, 2016
Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy (VitK-CUA) | NCT02278692
Calciphylaxis in peritoneal dialysis patients: a single center cohort study. Int J Nephrol Renovasc Dis (2016) 0.75
K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency. J Am Soc Nephrol (2017) 0.75
A case report of severe calciphylaxis - suggested approach for diagnosis and treatment. BMC Nephrol (2017) 0.75
Calcific Uremic Arteriolopathy Revisited. J Am Soc Nephrol (2016) 0.75
Role of Vitamin D in Uremic Vascular Calcification. Biomed Res Int (2017) 0.75
Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy. Int Urol Nephrol (2017) 0.75
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol (2006) 4.94
Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int (2002) 4.38
Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J (1973) 4.13
A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant (2011) 3.49
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant (2010) 3.10
Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery (1997) 2.82
Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol (2013) 1.97
Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int (2001) 1.75
Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis (2015) 1.69
Calciphylaxis: a still unmet challenge. J Nephrol (2011) 1.60
Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients. Am J Kidney Dis (1996) 1.51
Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol (2011) 1.29
A case control study of proximal calciphylaxis. Am J Kidney Dis (1998) 1.19
Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis (2007) 1.18
Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis (2001) 1.17
Statin use and calcific uremic arteriolopathy: a matched case-control study. Am J Nephrol (2013) 1.04
Observational studies versus randomized controlled trials: avenues to causal inference in nephrology. Adv Chronic Kidney Dis (2012) 1.04
Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis. Circulation (2015) 1.02
Quantifying a rare disease in administrative data: the example of calciphylaxis. J Gen Intern Med (2014) 1.01
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. Clin J Am Soc Nephrol (2015) 1.00
Calcific uremic arteriolopathy: a call for action. Semin Nephrol (2014) 0.92
Calcium use increases risk of calciphylaxis: a case-control study. Perit Dial Int (1999) 0.86
Calciphylaxis and the cardiometabolic syndrome. J Cardiometab Syndr (2006) 0.85
Painful skin ulcers in a hemodialysis patient. Clin J Am Soc Nephrol (2013) 0.84
Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases. Clin J Am Soc Nephrol (2015) 0.84
Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact? Atherosclerosis (2015) 0.83
Adipocyte induced arterial calcification is prevented with sodium thiosulfate. Biochem Biophys Res Commun (2014) 0.79
Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease. Nephron (2015) 0.79
Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients. Am J Kidney Dis (1997) 0.78
Heritability of Risk for Sudden Cardiac Arrest in ESRD. J Am Soc Nephrol (2015) 0.78